Preview

Russian Ophthalmological Journal

Advanced search

Efficacy of platelet-rich plasma lysate in patients with corneal erosion or post-traumatic scarring of the tissues of the eyelids

https://doi.org/10.21516/2072-0076-2020-13-3-8-14

Abstract

Purpose: to evaluate the effectiveness of platelet-rich plasma (PRP) lysate in patients with corneal erosion or posttraumatic scarring of eyelid tissues.

Material  and methods. The study involved 30 patients aged 22 to 82 (51.5 ± 19.1 years): 10 with persistent corneal erosions, who were treated in 2 stages (2 weeks of standard keratoprotective therapy, then treatment supplemented  with instillations of PRP lysate) and 20 patients with post-traumatic  scarring of eyelid tissues, who were divided into a clinical group and a comparison group. PRP lysate was produced in the cell transplantation  and immunotyping  laboratory of N.V.  Sklifosovsky Research  Institute  for Emergency Medicine.

Results. In group 1, already on the 3rd day of PRP lysate use, a positive dynamic of the cornea was observed: all patients had fewer complaints of pain, photophobia, and lacrimation. Corneal biomicroscopy, performed daily over the entire epithelization period, revealed a decrease in hyperemia of the tarsal and bulbar conjunctiva and corneal edema, which indicated a weakened inflammatory response. On average, the area of the cornea at the start of traditional therapy was 21.6 [19.6; 30.65] mm2. After two weeks of treatment, at the time of adding PRP lysate, the average area of erosion fell to 15.7 [12; 18.9] mm2, after a week of treatment with lysate, it dropped to an average of 2.35 [0.4; 4.3] mm2. On day 14, all patients revealed complete epithelialization  of the corneal defect. In patients with post-traumatic  eyelid tissue scars, after a 3-month-long use of PRP lysate (study group), an improvement  was noted in the cosmetic and functional  state of the eyelids, on average by 4 points (Me = 12 [10; 12] points before and 8.5 [8; 9] points after treatment (on the Manchester scar assessment scale), in contrast to the patients who received no anti-scar  therapy (comparison group), as the latter showed a deterioration in the condition of eyelid scars by 1–2 points (Me = 11 [10.25; 11.75] points at the beginning and 12 [11; 12] points at the end of the observation period). The acoustic density of scar tissue in the study group approached the normal values, in contrast to the comparison group, in which scar tissue appeared to be hypoechoic.

Conclusion. Using PRP lysate aimed at improving the repair and regeneration processes in patients with corneal erosion or post-traumatic  scarring of eyelid tissues is promising and requires further clinical study.

About the Authors

N. V. Borovkova
N.V. Sklifosovsky Research Institute for Emergency Medicine
Russian Federation

Natalia V. Borovkova — Dr.  of Med.  Sci.,  head  of the laboratory of cell transplantation and immunotyping.

3, Bolshaya Sukharevskaya Square, Moscow, 129090



I. A. Filatova
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation

Irina A. Filatova — Dr.  of Med.  Sci.,  head  of the  department of plastic surgery and eye prosthetics.

14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062



E. V. Chentsova
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation

Ekaterina V. Chentsova — Dr.  of Med.  Sci.,  professor, head  of the department of traumatology.

14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062



E. V. Fedoseeva
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation

Elena V. Fedoseeva — ophthalmologist, department of traumatology.

14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062



Yu. A. Pavlenko
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation

Yuri A. Pavlenko — PhD student, department of plastic  surgery and eye prosthetics.

14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062



I. N. Ponomarev
N.V. Sklifosovsky Research Institute for Emergency Medicine
Russian Federation

Ivan N. Ponomarev — Cand. of Med. Sci., surgeon, researcher, laboratory of cell transplantation and immunotyping.

14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062



S. A. Shemetov
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation

Sergey  A. Shemetov  — Cand. of Med.  Sci.,  ophthalmic surgeon, department of plastic surgery and eye prosthetics.

14/19, Sadovaya-Chernogryazskaya St., Moscow, 105062



A. O. Petrova
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation

Alena O. Petrova — ophthalmic surgeon, junior  researcher, department of traumatology.

3, Bolshaya Sukharevskaya Square, Moscow, 129090



References

1. Chentsova E.V., Fedoseeva E.V., Ponomarev I.N., Borovkova N.V. Method for treating corneal defects using an autologous thrombofibrin clot. Patent RF 2699206; 2019 (in Russian).

2. Filatova I.A., Kiseleva T.N., Iomdina E.N., et al. Echodensitometry in assessing the acoustic properties of eyelid tissues in normal and scar deformities. Point of view. EastWest. 2015; 1: 236–7 (in Russian).

3. Filatova I.A., Romanova I.A. the First experience of using the laser Doppler flowmetry method in assessing the state of scars at various terms. Vestnik OGU. 2010; 12: 234–6 (in Russian).

4. Fedoseeva E.V., Chentsova E.V., Borovkova N.V., Alekseeva I.B., Romanova I.Yu. Morphofunctional peculiarities of platelet rich plasma and its application in ophthalmology. Ophthalmology in Russia. 2018; 15 (4): 388–93 (in Russian). https://doi.org/10.18008/1816

5. Leo M.S., Kumar A.S., Kirit R., Konathan R., Sivamani R.K. Systematic review of the use of platelet-rich plasma in aesthetic dermatology. J. Cosmet. Dermatol. 2015 Dec; 14 (4): 315–23. https://doi.org/10.1111/jocd.12167

6. Makarov M.S., Kobzeva E.N., Vysochin I.V., Borovkova N.V., Khvatov V.B. Morphofunctional analysis of human platelets using vital staining. Bulletin of experimental biology and medicine. 2013; 156: 9: 388–91 (in Russian).

7. Nishida T., Nakamura M., Ofuji K., et al. Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea. J. Cell Physiol. 1996 Oct; 169 (1): 159–66. doi: 10.1002/(SICI)1097-4652(199610)169:1<159:AID-JCP16>3.0.CO;2-8

8. Van Setten G.B., Viinikka L., Tervo T., et al. Epidermal growth factor is a constant component of normal human tear fluid. Graefes Arch. Clin. Exp. Ophthalmol. 1989; 227; 184–7. doi: 10.1007/BF02169794

9. Gupta A., Monroy D., Ji Z., et al. Transforming growth factor beta-1 and beta-2 in human tear fluid. Curr. Eye Res. 1996 Jun; 15 (6): 605–14. doi: 10.3109/02713689609008900

10. Fedoseeva E.V., Chentsova E.V., Borovkova N.V., et al. Case of autologous thrombofibrin clot application in a patient with post-burn persistent corneal erosion. Transplantologiya. The Russian journal of transplantation. 2019; 11 (2): 150–7 (in Russian). https://doi.org/10.23873/2074-0506-2019-11-2-150-157

11. Ponomarev I.N., Sakharova O.M., Makarov M.S., Malygina M.A., Borovkova N.V. Method of treatment of patients with shoulder neck fracture. Patent RF № 0002681753; 2019 (in Russian).

12. Fearmonti R., Bond J., Erdmann D., Levinson H. A review of scar scales and scar measuring devices. Eplasty. 2010; 10:e43. Published 2010 Jun 21. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890387/


Review

For citations:


Borovkova N.V., Filatova I.A., Chentsova E.V., Fedoseeva E.V., Pavlenko Yu.A., Ponomarev I.N., Shemetov S.A., Petrova A.O. Efficacy of platelet-rich plasma lysate in patients with corneal erosion or post-traumatic scarring of the tissues of the eyelids. Russian Ophthalmological Journal. 2020;13(3):8-14. (In Russ.) https://doi.org/10.21516/2072-0076-2020-13-3-8-14

Views: 1150


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-0076 (Print)
ISSN 2587-5760 (Online)